SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
12-Jul-18 4:45 PM View: | Loxo Oncology, Inc. (LOXO) | 10-Jul-18 | Market Sale | 1,400,000 | $179.43 | $251,202,000.00 | (41%) 3.44M to 2.04M | (31%) |
20-Dec-17 4:31 PM View: | Loxo Oncology, Inc. (LOXO) | 19-Dec-17 | Market Sale | 250,000 | $80.50 | $20,125,000.00 | (7%) 3.69M to 3.44M | (192%) |
27-Nov-17 7:29 PM View: | Loxo Oncology, Inc. (LOXO) | 22-Nov-17 | Market Sale | 500,000 | $75.00 | $37,500,000.00 | (12%) 4.19M to 3.69M | (213%) |
12-Jan-17 5:17 PM View: | Loxo Oncology, Inc. (LOXO) | 10-Jan-17 | Private Purchase | 160,000 | $31.00 | $4,960,000.00 | 4% 4.03M to 4.19M | |
06-Jul-16 5:10 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 06-Jul-16 | Conversion | 508,565 | -- | -- | 100% 0 to 508.56K | |
06-Jul-16 5:10 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 06-Jul-16 | Purchase | 400,000 | $12.50 | $5,000,000.00 | 79% 508.56K to 908.57K | |
03-Jun-16 4:55 PM View: | Agile Therapeutics, Inc. (AGRX) | 02-Jun-16 | Disposition (other) | 400,000 | -- | -- | (13%) 2.98M to 2.58M | |
19-May-16 4:24 PM View: | Loxo Oncology, Inc. (LOXO) | 17-May-16 | Private Purchase | 232,558 | $21.50 | $5,000,000.00 | 6% 3.8M to 4.03M | |
15-Dec-15 6:28 PM View: | Loxo Oncology, Inc. (LOXO) | 11-Dec-15 | Market Purchase | 200 | $27.50 | $5,500.00 | < 1% 3.8M to 3.8M | 702% |
09-Dec-15 4:47 PM View: | T2 Biosystems, Inc. (TTOO) | 09-Dec-15 | Purchase | 307,692 | $9.75 | $3,000,000.00 | 12% 2.52M to 2.83M | |
19-Nov-15 5:34 PM View: | Loxo Oncology, Inc. (LOXO) | 17-Nov-15 | Private Purchase | 265,000 | $26.50 | $7,022,500.00 | 8% 3.53M to 3.8M | |
16-Nov-15 5:16 PM View: | Loxo Oncology, Inc. (LOXO) | 13-Nov-15 | Market Purchase | 1,955 | $27.47 | $53,704.20 | < 1% 3.53M to 3.53M | 703% |
16-Nov-15 5:16 PM View: | Loxo Oncology, Inc. (LOXO) | 12-Nov-15 | Market Purchase | 76,714 | $27.65 | $2,121,320.00 | 2% 3.45M to 3.53M | 698% |
29-Jan-15 5:10 PM View: | Aravive, Inc. (ARAV) | 27-Jan-15 | Private Purchase Duplicate | 145,000 | $17.25 | $2,501,250.00 | 7% 1.99M to 2.14M | |
27-Jan-15 4:25 PM View: | Agile Therapeutics, Inc. (AGRX) | 23-Jan-15 | Private Purchase Duplicate | 811,966 | $5.85 | $4,750,000.00 | 37% 2.17M to 2.98M | |
14-Aug-14 4:34 PM View: | T2 Biosystems, Inc. (TTOO) | 12-Aug-14 | Conversion | 2,068,760 | -- | -- | 100% 0 to 2.07M | |
14-Aug-14 4:34 PM View: | T2 Biosystems, Inc. (TTOO) | 12-Aug-14 | Purchase | 454,545 | $11.00 | $5,000,000.00 | 22% 2.07M to 2.52M | |
06-Aug-14 4:11 PM View: | Loxo Oncology, Inc. (LOXO) | 06-Aug-14 | Conversion | 2,850,710 | -- | -- | 1511% 188.71K to 3.04M | |
06-Aug-14 4:11 PM View: | Loxo Oncology, Inc. (LOXO) | 06-Aug-14 | Market Purchase | 413,077 | $13.00 | $5,370,000.00 | 14% 3.04M to 3.45M | 1598% |
22-May-14 4:20 PM View: | Durata Therapeutics, Inc. (DRTX) | 20-May-14 | Disposition (other) | 749,258 | -- | -- | (25%) 3.04M to 2.29M | |
23-Apr-14 4:48 PM View: | SafeStitch Medical, Inc. (TRXC) | 21-Apr-14 | Market Purchase | 1,037,770 | $4.00 | $4,151,070.00 | 14% 7.3M to 8.34M | (92%) |
27-Mar-14 6:34 PM View: | Aravive, Inc. (ARAV) | 26-Mar-14 | Conversion | 1,934,570 | -- | -- | 100% 0 to 1.93M | |
27-Mar-14 6:34 PM View: | Aravive, Inc. (ARAV) | 26-Mar-14 | Purchase Duplicate | 60,000 | $21.00 | $1,260,000.00 | 3% 1.93M to 1.99M | |
21-Mar-14 8:08 PM View: | Durata Therapeutics, Inc. (DRTX) | 21-Mar-14 | Market Sale | 2,649 | $15.57 | $41,255.00 | (< 1%) 3.03M to 3.03M | (54%) |
21-Mar-14 8:08 PM View: | Durata Therapeutics, Inc. (DRTX) | 20-Mar-14 | Market Sale | 98,000 | $15.74 | $1,542,590.00 | (3%) 3.13M to 3.03M | (53%) |
10-Dec-13 4:46 PM View: | SafeStitch Medical, Inc. (TRXC) | 06-Dec-13 | Conversion | 12,401,800 | -- | -- | 51% 24.09M to 36.49M | |
25-Jul-12 5:08 PM View: | Durata Therapeutics, Inc. (DRTX) | 24-Jul-12 | Conversion | 2,019,710 | -- | -- | 100% 0 to 2.02M | |
25-Jul-12 5:08 PM View: | Durata Therapeutics, Inc. (DRTX) | 24-Jul-12 | Purchase | 1,111,110 | $9.00 | $10,000,000.00 | 55% 2.02M to 3.13M |